Correspondence 0001104659-24-048245 from ORTHOPEDIATRICS CORP (KIDS)

ORTHOPEDIATRICS CORP
Date: April 17, 2024 · CIK: 0001425450 · Accession: 0001104659-24-048245

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-277996

Date

April 17, 2024

Author

Form

CORRESP

Company

ORTHOPEDIATRICS CORP

Letter

OrthoPediatrics Corp.

2850 Frontier Drive

Warsaw, Indiana 46582

April 17, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jessica Ansart

Re: OrthoPediatrics Corp.

Registration Statement on Form S-3

File No. 333-277996

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended, OrthoPediatrics Corp., a Delaware corporation (the “Company”), hereby respectfully requests that effectiveness of the above-referenced Registration Statement be accelerated by the Securities and Exchange Commission to 4:00 p.m. (Eastern Time) on April 19, 2024, or as soon as practicable thereafter.

Please contact Jeremy E. Hill of Dentons Bingham Greenebaum LLP, counsel to the Company, at (317) 968-5384 with any questions you may have regarding this request.

Sincerely,
OrthoPediatrics Corp.

Show Raw Text

CORRESP
1
filename1.htm

    OrthoPediatrics Corp.

    2850 Frontier Drive

    Warsaw, Indiana 46582

April 17, 2024

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Jessica Ansart

Re:           OrthoPediatrics
Corp.

Registration Statement on Form S-3

File No. 333-277996

Acceleration Request

Ladies and Gentlemen:

Pursuant to Rule 461 of the Securities Act of 1933, as amended,
OrthoPediatrics Corp., a Delaware corporation (the “Company”), hereby respectfully requests that effectiveness of the above-referenced
Registration Statement be accelerated by the Securities and Exchange Commission to 4:00 p.m. (Eastern Time) on April 19, 2024,
or as soon as practicable thereafter.

Please contact Jeremy E. Hill of Dentons Bingham Greenebaum LLP, counsel
to the Company, at (317) 968-5384 with any questions you may have regarding this request.

    Sincerely,

    OrthoPediatrics Corp.

    By:
    /s/ Daniel J. Gerritzen

    Daniel J. Gerritzen, General Counsel, Executive Vice President of Legal, and Secretary

 cc: Jeremy E. Hill, Dentons Bingham Greenebaum LLP

SecProbe.io